Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CleanSpace HoldingsASX:CSX +9.72%21 Days Sales Outstanding is 67.35 as of Dec. 2025, which is 21% above its 10-year median of 55.52. GuruFocus rates ASX:CSX with a GF Score™ of 21/100 and a GF Value™ of A$0.56 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 810 Medical Devices & Instruments companies, CleanSpace Holdings ranks worse than 55.19% on this metric.
The historical rank and industry rank for CleanSpace Holdings's Days Sales Outstanding or its related term are showing as below:
ASX:CSX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.21 Med: 55.52 Max: 69.67
Current: 69.67
During the past 6 years, CleanSpace Holdings's highest Days Sales Outstanding was 69.67. The lowest was 38.21. And the median was 55.52.
ASX:CSX's Days Sales Outstanding is ranked worse than 55.19% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.165
vs ASX:CSX: 69.67
CleanSpace Holdings's Days Sales Outstanding
declined
from Dec. 2024 (71.45) to Dec. 2025 (67.35).
CleanSpace Holdings (ASX:CSX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
CleanSpace Holdings Days Sales Outstanding Related Terms
CleanSpace Holdings Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for CleanSpace Holdings's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CSX vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, CleanSpace Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CleanSpace Holdings Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CleanSpace Holdings's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where CleanSpace Holdings's Days Sales Outstanding falls into.
CleanSpace Holdings Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CleanSpace Holdings (ASX:CSX) has a Days Sales Outstanding of 67.35 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on CleanSpace Holdings and its competitors. This is 21% above median its historical median of 55.52. Over the past decade, CleanSpace Holdings' Days Sales Outstanding has ranged from 38.21 to 69.67. According to the industry distribution chart, CleanSpace Holdings ranks #447 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 55.2%.
Is CleanSpace Holdings' Days Sales Outstanding too high?
CleanSpace Holdings' current Days Sales Outstanding of 67.35 is 21% above median its 10-year median of 55.52. Over the past 10 years, this metric has ranged from a low of 38.21 to a high of 69.67. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.17. CleanSpace Holdings' value of 67.35 is 3.4% above this industry median. Based on the distribution chart, CleanSpace Holdings ranks #447 out of 810 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CleanSpace Holdings has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CleanSpace Holdings' Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CleanSpace Holdings ranks #447 out of 810 companies for Days Sales Outstanding. This places CleanSpace Holdings in the lower half of its industry. The industry median Days Sales Outstanding is 65.17. CleanSpace Holdings' value of 67.35 is 3.4% above this benchmark. Historically, CleanSpace Holdings' own Days Sales Outstanding has ranged from 38.21 to 69.67 over the past decade. While the company's 10-year median is 55.52 vs. the industry median of 65.17, CleanSpace Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.17, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CleanSpace Holdings's current Days Sales Outstanding of 67.35 is 3.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on CleanSpace Holdings and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CleanSpace Holdings's current Days Sales Outstanding is 67.35, which is 21% above median its own 10-year median of 55.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CleanSpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, CleanSpace Holdings (ASX:CSX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.56, compared to a current price of A$0.40 — trading 29.5% below its estimated fair value. The current Days Sales Outstanding is 67.35, which is 21% above median its 10-year median of 55.52 and 3.4% above the Medical Devices & Instruments industry median of 65.17. CleanSpace Holdings' overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For CleanSpace Holdings (ASX:CSX), the current Days Sales Outstanding is 67.35 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CleanSpace Holdings (ASX:CSX) Overvalued in 2026?
Based on GuruFocus' analysis, CleanSpace Holdings stock appears to be undervalued.
The current stock price of A$0.40 is trading 29.5% below its estimated GF Value™ of A$0.56.
GuruFocus considers CleanSpace Holdings to be Modestly Undervalued.
Key valuation signals for ASX:CSX:
Days Sales Outstanding: 67.35 (21% above median its 10-year median of 55.52)
GF Value™: A$0.56 vs. price of A$0.40 (29.5% below fair value)
Industry Position: 3.4% above the Medical Devices & Instruments median (#447 of 810)
No single metric tells the full story. See the ASX:CSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CleanSpace Holdings Ltd manufactures and sells respirators and related products and services. Its products include Compare, CleanSpace HALO, CleanSpace ULTRA, Masks, Filters, and Compatible Products. The company's operating segment is based on regions that include, Europe, Asia, and North America, and the majority of its revenue is generated from Europe.
21GF Score
Get the complete analysis for ASX:CSX
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CSX has been successfully added to your 
